NovaBay Pharmaceuticals, Inc. (NBY) financial statements (2021 and earlier)

Company profile

Business Address 2000 POWELL STREET, SUITE 1150
EMERYVILLE, CA 94608
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments733102513
Cash and cash equivalents733102511
Short-term investments      3
Receivables1342101
Inventory, net of allowances, customer advances and progress billings0011110
Inventory0011110
Prepaid expense0002011
Other current assets000  513
Other undisclosed current assets111  (5)(13)
Total current assets:999145715
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0000001
Other noncurrent assets0111000
Total noncurrent assets:2111111
TOTAL ASSETS:11910155816
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2422432
Accounts payable0100222
Accrued liabilities232221 
Deferred revenue0
Debt2      
Derivative instruments and hedges, liabilities0      
Deferred revenue and credits32000
Contract with customer, liability2
Other liabilities      2
Other undisclosed current liabilities1(2)    (0)
Total current liabilities:6454534
Noncurrent Liabilities
Long-term debt and lease obligation1      
Operating lease, liability1
Liabilities, other than long-term debt 013422
Deferred revenue and credits12222
Deferred rent credit 0
Other liabilities 00010 
Other undisclosed noncurrent liabilities40112 2
Total noncurrent liabilities:5134624
Total liabilities:104781067
Stockholders' equity
Stockholders' equity attributable to parent, including:1537(5)7365
Common stock0000010
Additional paid in capital126120114111857364
Accumulated other comprehensive loss      (0)
Accumulated deficit(125)(115)(111)(104)(91)  
Warrants and rights outstanding  1    
Other undisclosed stockholders' equity attributable to parent  (1)    
Other undisclosed stockholders' equity     (72)(56)
Total stockholders' equity:1537(5)29
TOTAL LIABILITIES AND EQUITY:11910155816

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues7131812403
Revenue, net1812413
Cost of revenue
(Cost of Goods and Services Sold)
(2)(2)(3)(2)(1)(0)(0)
Other undisclosed gross profit     0(3)
Gross profit:511159300
Operating expenses (19)(23)(20)(24)(17)(19)
Other undisclosed operating income     03
Operating income (loss):5(8)(7)(11)(21)(17)(15)
Nonoperating income (expense) 00(2)220
Investment income, nonoperating   (2)22 
Other nonoperating income (expense) 00(0)(0)00
Interest and debt expense(0)      
Other undisclosed loss from continuing operations before equity method investments, income taxes      (1)
Income (loss) from continuing operations before equity method investments, income taxes:5(8)(7)(13)(19)(15)(16)
Other undisclosed income (loss) from continuing operations before income taxes(14)1(0)    
Loss from continuing operations before income taxes:(10)(7)(7)(13)(19)(15)(16)
Income tax expense (0)(0)(0)(0)(0)(0)
Loss before gain (loss) on sale of properties:(10)(7)(7)(13)(19)(15)(16)
Other undisclosed net loss    (0)  
Net loss:(10)(7)(7)(13)(19)(15)(16)
Other undisclosed net loss attributable to parent(0)      
Net loss attributable to parent:(10)(7)(7)(13)(19)(15)(16)
Preferred stock dividends and other adjustments(1)      
Net loss available to common stockholders, basic:(10)(7)(7)(13)(19)(15)(16)
Dilutive securities, effect on basic earnings per share (1)     
Net loss available to common stockholders, diluted:(10)(8)(7)(13)(19)(15)(16)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(10)(7)(7)(13)(19)(15)(16)
Comprehensive loss:(10)(7)(7)(13)(19)(15)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent     0(0)
Comprehensive loss, net of tax, attributable to parent:(10)(7)(7)(13)(19)(15)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: